Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Seminars in Liver Disease Année : 2021

Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play

Résumé

Safe and effective treatment with direct-acting antivirals (DAAs) has ushered in an era in which hepatitis C virus (HCV) elimination, as set out by the World Health Organization, is possible. However, alcohol use disorder (AUD) has the potential to reduce the benefits of prevention interventions and reduce access to and continuity of HCV care in at-risk populations, such as people who inject drugs (PWID). We review the literature on the consequences of AUD on the effectiveness of HCV prevention and the cascade of care in PWID and provide recommendations for future research in the field of alcohol use and HCV.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03121677 , version 1 (26-01-2021)

Identifiants

Citer

Fabienne Marcellin, Antoine Jaquet, Jeffrey V Lazarus, Patricia Molina, Patrizia M. Carrieri. Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play. Seminars in Liver Disease, 2021, 41 (2), pp.109-116. ⟨10.1055/s-0040-1716343⟩. ⟨inserm-03121677⟩
48 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More